bioAffinity Technologies (BIAF) Current Leases (2023 - 2025)
Historic Current Leases for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $136197.0.
- bioAffinity Technologies' Current Leases fell 6487.78% to $136197.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136197.0, marking a year-over-year decrease of 6487.78%. This contributed to the annual value of $395301.0 for FY2024, which is 816.44% up from last year.
- Per bioAffinity Technologies' latest filing, its Current Leases stood at $136197.0 for Q3 2025, which was down 6487.78% from $179844.0 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Current Leases ranged from a high of $403584.0 in Q1 2025 and a low of $136197.0 during Q3 2025
- In the last 3 years, bioAffinity Technologies' Current Leases had a median value of $372787.0 in 2024 and averaged $331055.2.
- Data for bioAffinity Technologies' Current Leases shows a peak YoY increase of 826.13% (in 2025) and a maximum YoY decrease of 6487.78% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows bioAffinity Technologies' Current Leases stood at $365463.0 in 2023, then grew by 8.16% to $395301.0 in 2024, then crashed by 65.55% to $136197.0 in 2025.
- Its Current Leases was $136197.0 in Q3 2025, compared to $179844.0 in Q2 2025 and $403584.0 in Q1 2025.